by Keishi Foecke | Mar 12, 2025 | Blog Post, PULSE Partner
In a recent op-ed for The Maryland Daily Record, Kelly Schulz, CEO of PULSE Partner Maryland Tech Council, discusses how federal policy against mergers and acquisitions (M&A) could undermine Maryland’s status as an innovation leader in the life sciences....
by Keishi Foecke | Feb 4, 2025 | Blog Post, PULSE Partner
In a recent op-ed for NJBIZ, Debbie Hart, President and CEO of PULSE Partner BioNJ, discusses how federal policy against mergers and acquisitions (M&A) could undermine New Jersey’s leadership in the life sciences. Read the op-ed below: As the “medicine chest of...
by Hanna | Dec 5, 2024 | Blog Post, PULSE Partner
In a recent op-ed for the Detroit News, Stephen Rapundalo, President and CEO of PULSE Partner MichBio, highlights the vital role of mergers and acquisitions (M&A) in fueling innovation and competition across Michigan’s life sciences ecosystem. As Rapundalo...
by Hanna | Nov 13, 2024 | Blog Post, PULSE Partner
In a recent blog post, PULSE partner Colorado Bioscience Association (CBSA) highlighted the fundamental role of pro-innovation mergers and acquisitions in driving life sciences innovation and economic growth in Colorado and beyond. Read their blog post below: In...
by Hanna | Oct 15, 2024 | Blog Post, PULSE Partner
Leading organizations are expressing concern about the impact of the Federal Trade Commission (FTC)’s final Hart-Scott-Rodino (HSR) premerger notification rule, including the chilling effect it could have on biopharmaceutical and life sciences innovation. While the...
by Hanna | May 21, 2024 | Blog Post, PULSE Partner
How mergers and acquisitions drive innovative cures and New Jersey’s economy New Jersey has long been home to some of the world’s leading research-based biopharmaceutical companies. Many have made New Jersey a base for their global, North American, or U.S. operations....